BriaCell Therapeutics Corp.

$0.00089999999 USD

$0.0 (-0.0%)

Volume: 186.08K
Average Volume: 71.38K
Market Capitalization: $1.7K
P/E Ratio: 0.00
Dividend Yield: 0.00%
Price Target

Year High: $0.06
Year Low: $0.00
Day High: —
Day Low: —
Payout Ratio: $0.00
Current Ratio: $7.07

Industry, Sector & symbol

Stock Exchange	NASDAQ
CEO	William V. Williams
Industry	Biotechnology
Sector	Healthcare
Current Symbol	BCTXW
CUSIP	None
CIK	0001610820
Web	https://briacell.com
Phone	604 921 1810
Currency	USD
Employees	16
Country	CA

Liquidity

Debt-to-Equity Ratio	0.00
Payout Ratio	0.00
Current Ratio	7.07
Quick Ratio	7.07
Cash Ratio	1.92

Sales & Book Value

Annual Sales	-$
Price / Sales	0.00
Cash Flow	-3.40
Price / Cash Flow	0.00
Price / Book	0.00

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecast Upside/Downside	%
Consensus Rating	N/A
Rating Score(0-5)	0
Research Coverage	0 Analysts

Profitability

EPS (Most Recent Fiscal Year)	-$62.95
Trailing P/E Ratio	0.00
PEG Ratio	0.00
P/E Growth	0.00
Net Income	-$26.63M
Net Margin	0.00%
Pretax Margin	0.00%
Return on Equity	-142.91%
Return on Assets	-112.77%

Financials Score

AltmanZ Score	-4.72
Piotroski Score	2.00
Working Capital	21.8M
Total Assets	27.07M
Ebit	10.31M
Market Cap	2.41K
Total Liabilities	3.66M

Poll Results

About BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Stock

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, currently in Phase 3, dedicated to revolutionizing cancer treatment through its innovative cellular immunotherapies. Its flagship product, Bria-IMT, is currently undergoing a pivotal Phase 3 clinical trial for advanced breast cancer, where it's being evaluated in combination with an immune checkpoint inhibitor. Beyond this lead candidate, the company is also advancing the development of personalized, off-the-shelf treatments designed to combat breast, prostate, and various other forms of cancer. Furthermore, BriaCell maintains a strategic partnership with Incyte Corporation, focused on further evaluating Bria-IMT in combination therapies. The company's operations are headquartered in West Vancouver, Canada. ...

Frequently Asked Questions

What is the current BriaCell Therapeutics Corp. (BCTXW) stock price?: BriaCell Therapeutics Corp.(NASDAQ:BCTXW) stock price is $0.00089999999 in the last trading session. During the trading session, BCTXW stock reached the peak price of $0.0645 while $0.0006 was the lowest point it dropped to. The percentage change in BCTXW stock occurred in the recent session was --0.0% while the dollar amount for the price change in BCTXW stock was -$0.0.
BCTXW's industry and sector of operation?: The NASDAQ listed BCTXW is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of BCTXW?: William V. Williams | Chief Executive Officer, President & Director
Gadi Levin | Chief Financial Officer & Corporate Secretary
Charles Louis Wiseman FACP | Founder, Principal Research Advisor & Member of Scientific Advisory Board
Miguel A. Lopez-Lago | Chief Scientific Officer
Giuseppe Del Priore | Chief Medical Officer
How many employees does BCTXW have?: Number of BCTXW employees currently stands at 16. BCTXW operates from Bellevue Centre, West Vancouver, BC V7T 2X1, CA.

Link for BCTXW official website?: Official Website of BCTXW is: https://briacell.com
How do I contact BCTXW?: BCTXW could be contacted at phone #604 921 1810 and can also be accessed through its website. BCTXW operates from Bellevue Centre, West Vancouver, BC V7T 2X1, CA.
How many shares of BCTXW are traded daily?: The average number of BCTXW shares traded daily for last 3 months was 71.38K.
What is the market cap of BCTXW currently?: The market value of BCTXW currently stands at $1.7K with its latest stock price at $0.00089999999